BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marcon PDS, Tovo CV, Kliemann DA, Fisch P, Mattos AA. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. World J Gastroenterol 2018; 24(5): 613-622 [PMID: 29434450 DOI: 10.3748/wjg.v24.i5.613] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hussain A, Hussain A, Afzal MF, Hussain R, Hameed M. Frequency of hidden Hepatitis B and C during screening in patients’ undergone surgical procedures: Single Centered study. PJHS 2022. [DOI: 10.54393/pjhs.v3i07.136] [Reference Citation Analysis]
2 Cammarata F, Benuzzi L, Crespi M, Troci A, Pennacchi L, Schiavini M, Foschi D. Liver resection of hepatocellular carcinoma in HIV-HCV co-infected patients: a retrospective case series. Egypt Liver Journal 2022;12:53. [DOI: 10.1186/s43066-022-00215-x] [Reference Citation Analysis]
3 Javed A, Malagraba G, Yarmohammadi M, Perelló-reus CM, Barceló C, Rubio-tomás T. Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System. Future Pharmacology 2022;2:214-237. [DOI: 10.3390/futurepharmacol2030015] [Reference Citation Analysis]
4 Fernandes SA, Tovo CV, da Silva ALM, Pinto LP, Carteri RB, Mattos AA. Relationship between phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus. World J Hepatol 2022;14:1173-81. [PMID: 35978664 DOI: 10.4254/wjh.v14.i6.1173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mehershanhi S, Haider A, Kandhi S, Sun H, Patel H. Prevalence of Hepatocellular Carcinoma in HIV Patients Co-infected or Triple Infected With Hepatitis B and Hepatitis C in a Community Hospital in South Bronx. Cureus 2022. [DOI: 10.7759/cureus.26089] [Reference Citation Analysis]
6 Li D, Lu L, Liu M, Sun J. Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p. Bioengineered 2022;13:11296-308. [PMID: 35484972 DOI: 10.1080/21655979.2022.2068289] [Reference Citation Analysis]
7 Zhao Y, Kong LX, Feng FS, Yang J, Wei G. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study. BMC Cancer 2022;22:311. [PMID: 35321670 DOI: 10.1186/s12885-022-09433-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Malagraba G, Yarmohammadi M, Javed A, Barceló C, Rubio-tomás T. The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update. Biomolecules 2022;12:462. [DOI: 10.3390/biom12030462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Saud LRC, Chagas AL, Maccali C, Pinto PVA, Horvat N, Alencar RSSM, Tani CM, Abdala E, Carrilho FJ. Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior? Eur J Gastroenterol Hepatol 2021;33:583-8. [PMID: 33560682 DOI: 10.1097/MEG.0000000000002057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Anugwom CM, Allaire M, Akbar SMF, Sultan A, Bollipo S, Mattos AZ, Debes JD. Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology. Hepatoma Res 2021;7:23. [PMID: 33884303 DOI: 10.20517/2394-5079.2021.06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kong L, Wei G, Lv T, Jiang L, Yang J, Zhao Y, Yang J. Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma. Sci Rep 2021;11:696. [PMID: 33436856 DOI: 10.1038/s41598-020-80311-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Al-busafi SA, Alnaamani K. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_17] [Reference Citation Analysis]
13 Yang X, Zhang J, Chen S, Weissman S, Olatosi B, Li X. Comorbidity patterns among people living with HIV: a hierarchical clustering approach through integrated electronic health records data in South Carolina. AIDS Care 2021;33:594-606. [PMID: 33172284 DOI: 10.1080/09540121.2020.1844864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Marcon PDS, de Mattos AZ, de Mattos AA. Letter to the Editor: Coinfection of Human Immunodeficiency Virus With Hepatitis C Virus: A Change of Paradigm. Hepatology 2020;72:782. [PMID: 31965583 DOI: 10.1002/hep.31123] [Reference Citation Analysis]
15 Tsai WC, Hsu WT, Liu WD, Sun HY, Chuang YC, Huang YS, Cheng A, Lin KY, Huang YC, Chen GJ, Huang SH, Sheng WH, Hsieh SM, Hung CC, Chang SC. Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection. Liver Int 2019;39:1408-17. [PMID: 30712284 DOI: 10.1111/liv.14059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
16 Cunha L, Carrilho C, Bhatt N, Loforte M, Maueia C, Fernandes F, Guisseve A, Mbofana F, Maibaze F, Mondlane L, Ismail M, Dimande L, Machatine S, Lunet N, Liu YT, Gudo ES, Pineau P. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/>. Cancer Treat Res Commun 2019;19:100129. [PMID: 30903933 DOI: 10.1016/j.ctarc.2019.100129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Gelu-Simeon M, Lewin M, Ostos M, Bayan T, Beso Delgado M, Teicher E, Layese R, Roudot-Thoraval F, Fontaine H, Sobesky R, Salmon-Céron D, Samuel D, Seror O, Nahon P, Meyer L, Duclos-Vallée JC; ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver Int 2019;39:136-46. [PMID: 29947467 DOI: 10.1111/liv.13921] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Ganesan M, Poluektova LY, Enweluzo C, Kharbanda KK, Osna NA. Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit. Biomolecules 2018;8. [PMID: 30322122 DOI: 10.3390/biom8040113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
19 Cui W, Fan W, Huang K, Wang Y, Lu M, Yao W, Li J. Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablation. International Journal of Hyperthermia 2018;35:239-45. [DOI: 10.1080/02656736.2018.1493235] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
20 Sang L, Wang XM, Xu DY, Zhao WJ. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma. World J Gastroenterol 2018; 24(24): 2605-2616 [PMID: 29962817 DOI: 10.3748/wjg.v24.i24.2605] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
21 Ružić M, Pellicano R, Fabri M, Luzza F, Boccuto L, Brkić S, Abenavoli L. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Med 2018;60:185-91. [PMID: 29856183 DOI: 10.23736/S0031-0808.18.03472-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]